Results 241 to 250 of about 158,388 (335)

FRI0260 High Rates of Remission Induction Achieved with Combination Etanercept Plus Methotrexate in Early Rheumatoid Arthritis up to One Year after Symptom Onset: Table 1. [PDF]

, 2014
Paul Emery, Jack F. Bukowski, Annette Szumski, Lisa Marshall   +3 more
openalex   +1 more source

Carbon‐Coated Probiotics Restore Intestinal Homeostasis to Promote Damage Repair in Inflammatory Bowel Disease

Advanced Science, EarlyView.
Carbon‐coated Lactobacillus rhamnosus GG (C dots@LGG) enhances the antioxidant effects of LGG and safeguards the probiotics to target the inflamed colon. This reduces inflammation and oxidative damage, repairs the intestinal barrier, regulates the microbiota, and alleviates colitis.
Xue Chen, Haiyan Guo, Yuhan Li, Qiaowen Lin, Hua Liu, Liwen Hong, Lei Wang, Jie Zhong, Dalong Ni, Zhengting Wang   +9 more
wiley   +1 more source

Gene expression profiles associated with early relapse during first remission induction in canine multicentric high-grade B-cell lymphoma. [PDF]

J Vet Med Sci
Toyoda H, Tani A, Goto-Koshino Y, Motegi T, Sakamoto M, Mochizuki T, Harada K, Kobayashi T, Setoguchi A, Shizuta Y, Mizuno T, Irie M, Nakamichi J, Tsujimoto H, Ohmi A, Fukuoka R, Nakamura Y, Tomiyasu H.   +17 more
europepmc   +1 more source

Plasma exchange for induction and cyclosporine A for maintenance of remission in Wegener's granulomatosis--a clinical randomized controlled trial

, 2010
Wladimir Szpirt, James Heaf, Jørgen Holm Petersen   +2 more
openalex   +1 more source

In Situ Vaccines in the Era of Cancer Immunotherapy: Conceptual Innovation and Clinical Translation

Advanced Science, EarlyView.
In this review, the basic concepts of in situ vaccination are discussed, its advantages over conventional vaccines, and key historical milestones, from the first use of Coley's toxins to the most recent FDA‐approved in situ vaccine for bladder cancer.
Yiru Shi, Yuxuan Hou, Moustafa T. Mabrouk, Chengzhong Yu, Yannan Yang   +4 more
wiley   +1 more source

Reduced-intensity therapy for pediatric lymphoblastic leukemia: impact of residual disease early in remission induction.

Blood, 2021
Sidhom I, Shaaban K, Youssef SH, Ali N, Gohar S, Rashed WM, Mehanna M, Salem S, Soliman S, Yassin D, Mansour E, Coustan-Smith E, Ribeiro RC, Rivera GK.   +13 more
europepmc   +1 more source

Central Nervous System Involvement in Childhood Acute Lymphoblastic Leukemia: An Analysis of Day-One Versus Day-Eight Lumbar Punctures in Remission Induction Therapy. [PDF]

Cureus, 2021
Arshad U, Jabbar N, Mansoor N, Haider M, Butt Z, Nadeem K.   +5 more
europepmc   +1 more source

Emergence of oligoclonal bands in patients with multiple myeloma in complete remission after induction chemotherapy: association with the use of novel agents

, 2010
Carlos Fernández de Larrea, Natalia Tovar, M. a. T. Cibeira, Juan I. Aróstegui, Laura Rosiñol, M. Elena, Xavier Filella, Jordi Yagüe, Joan Bladé   +8 more
openalex   +2 more sources

P396. Adalimumab induction therapy achieves clinical remission and response in chinese patients with Crohn's Disease [PDF]

, 2015

openalex   +1 more source

Emerging cGAS‐STING Agonist‐Based Nanotherapeutics: Mechanistic Insights and Applications in Cancer Combination Therapy

Advanced Science, EarlyView.
This review summarizes recent advances in cGAS‐STING agonist‐based nanotherapeutics for cancer combination therapy. It explores nanoparticle‐mediated delivery strategies, underlying molecular mechanisms, and combinatorial applications with chemotherapy, radiotherapy, targeted therapy, phototherapy, sonodynamic therapy, and immunotherapy.
Zhaomeng Wang, Yongjun Wang, Zhonggui He, Caigang Liu   +3 more
wiley   +1 more source